Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy
Fatemeh Babajani, Atefeh Kakavand, Hossien Mohammadi, et al.
Health Science Reports (2021) Vol. 4, Iss. 4
Open Access | Times Cited: 19

Showing 19 citing articles:

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
Girolamo Giannotta, Antonio Murrone, Nicola Giannotta
Vaccines (2023) Vol. 11, Iss. 4, pp. 747-747
Open Access | Times Cited: 29
The influence of genetic polymorphisms on cytokine profiles in pediatric COVID-19: a pilot study
Kateryna Kozak, Halyna Pavlyshyn, Oleksandr Kamyshnyi, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes?
Alok Kumar Paul, Md. Kamal Hossain, Tooba Mahboob, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 321-321
Open Access | Times Cited: 23
N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions
José Luis Izquierdo, Sandra Pérez-Rial, Carolina Gotera Rivera, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 12, pp. 1477-1483
Open Access | Times Cited: 23
Post-stroke rehabilitation in the peri-pandemic COVID-19 era
Meirgul I. Assylbek, Burhan Fatih Koçyiğit, Marlen Yessirkepov, et al.
Rheumatology International (2024) Vol. 44, Iss. 3, pp. 399-411
Closed Access | Times Cited: 4
ACE I/D polymorphism is a risk factor for the clinical severity of COVID-19 in Brazilian male patients
Sandro Soares de Almeida, Marcos Fernandes Gregnani, Isabela Moreira Gontijo da Costa, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Gene variants rs5182, rs2074192, and rs4343 in the renin-angiotensin-aldosterone system are associated with symptom severity, higher odds of hospitalization, and death in COVID-19
Margarita L. Martínez‐Fierro, Aurelio Perez-Favila, Sidere M Zorrilla-Alfaro, et al.
International Journal of Infectious Diseases (2024) Vol. 144, pp. 107067-107067
Open Access | Times Cited: 1
Advances in Angiotensin Converting Enzyme-2 and Renin Angiotensin System Against COVID 19: A Pharmacotherapy and Physicochemical Review
Suhad Hafidh
Research Review (2023)
Open Access | Times Cited: 4
Vitamin D and estrogen steroid hormones and their immunogenetic roles in Infectious respiratory (TB and COVID-19) diseases
Maria Eduarda de Albuquerque Borborema, Thays Maria Costa de Lucena, Jaqueline de Azevêdo Silva
Genetics and Molecular Biology (2023) Vol. 46, Iss. 1 suppl 2
Open Access | Times Cited: 2
The Serum ACE2, CTSL, AngII, and TNFα Levels after COVID-19 and mRNA Vaccines: The Molecular Basis
Mina Pencheva, Martina Bozhkova, Yordan Kalchev, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3160-3160
Open Access | Times Cited: 2
Prognostic Impact of Dysnatremia in COVID-19 Pneumonia: Risk Stratification of Hospitalized Patients
Madhumita Das, Angela Phukan, Madhab Kalita
Research Square (Research Square) (2024)
Open Access
Evaluation of angiotensin converting enzyme 2 (ACE2), angiotensin II (Ang II), miR-141-3p, and miR-421 levels in SARS-CoV-2 patients: a case-control study
Ehsan Kakavandi, Kaveh Sadeghi, Mohammad Shayestehpour, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients
Mihaela Zlosa, Barbara Grubišić, Luka Švitek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9856-9856
Open Access
The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among Covid-19 patients
Seyede Mahboobeh Raoofi Kelachayeh, Maryam Haddadzadeh Shoushtari, Zahra Mehraban, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11282-e11282
Open Access | Times Cited: 3
Emerging Contributions of Endocrine Pathophysiology in Virus-Related Infectious Disease: Focus on the RAAS in COVID-19 and HIV
Teressa S Thomas, Suman Srinivasa
Advances in biochemistry in health and disease (2023), pp. 53-77
Closed Access | Times Cited: 1
The Effect of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Severity and Death Rate of COVID-19 in Iranian Patients
Mohammad Samet, Mehran Yazdi, Masoud Tajamolian, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 5, pp. 3568-3585
Open Access
Renin-Angiotensin-Aldosterone axis inhibition improves outcome of diabetic patients with chronic hypertension and COVID-19: An Iranian perspective
Hadiseh Hosamirudsari, Zahedin Kheyri, Mahboobeh Alizadeh, et al.
Advanced Biomedical Research (2022) Vol. 11, Iss. 1, pp. 109-109
Open Access
Renin-Angiotensin-Aldosterone Axis Inhibition Improves Outcome of Diabetic Patients with Chronic Hypertension and COVID-19
Zahedin Kheyri, Mahboobeh Alizadeh, Samaneh Akbarpour, et al.
Advanced Biomedical Research (2022) Vol. 11, Iss. 1, pp. 109-109
Open Access
Page 1

Scroll to top